2015 AACC

The new HER2 BLOOD TEST from NUCLEA BIOTECHNOLGIES

The new HER2 ELISA is a simple, non-invasive serum test that can be used as a clinical tool for monitoring and managing MBC patients HER-2 levels for changes in clinical status such as response to therapy or progression of disease.